[Fishman肺部疾病 第5版上下两册 英文版 医学内科学呼吸科 肺部影像学图谱肺部呼吸道感染呼吸衰竭 新华书店正版]
Вес товара: ~0.7 кг. Указан усредненный вес, который может отличаться от фактического. Не включен в цену, оплачивается при получении.
Описание товара
[ 本书阐述了呼吸系统生物学、细胞学及分子机制、正常和疾病状态下的肺功能及相应的改变，并全面、详细介绍了多种呼吸系统疾病及其影响因素，其中包括阻塞性肺疾病和限制性肺疾病、肺血管病、睡眠呼吸障碍、肺部肿瘤、呼吸道感染、呼吸衰竭等。本书D5版对肺病医学的发展、干细胞和呼吸系统疾病、肺疾病遗传学与精准医疗等内容进行了更新。全书共500万余字，2000余幅图，60个视频，18000条参考文献。本书是呼吸科临床医生、实习生、肺部疾病研究人员必不可少的工具书。 ]
[ 简 目 Contributors Preface Volume 1 Part 1:Perspectives Part 2: ScientificBasis of lung Function in Health and Disease Section 1 Genetic,Cellular, and Structural Basis of Normal Lung Function Section 2 PhysiologicalPrinciples of NormalLung Function Section 3 TheLungsin Different Physiological States Section 4 LungImmuDlogy Section 5 LungInjury and Repair Part 3: Symptomsand Signs of respiratory Disease Section 6 Clinical Approach to the Patient ]
[简]&[nbsp; 目]
Contributors
Preface
Volume 1
Part 1: Perspectives
[Part 2: Scientific Basis of lung Function in Health and Disease]
Section 1 &[nbsp; Genetic, Cellular, and Structural Basis of Normal] Lung Function
Section 2 &[nbsp; Physiological Principles of NormalLung Function]
Section 3 &[nbsp; The Lungsin Different Physiological States]
Section 4 Lung ImmuDlogy
Section 5 Lung Injury and Repair
[Part 3: Symptoms and Signs of respiratory Disease]
Section 6 Clinical Approach to the Patient
Section 7 DiagDstic Procedures
Part 4: Obstructive Lung Diseases
Section 8 Chronic Obstructive Pulmonary Disease
Section 9 Asthma
Section 10 Other Obstructive Disorders
[Part 5: interstitial and inflammatory lung Diseases]
Section 11 ImmuDlogic and Interstitial Diseases
Part 6: Drug-induced lung Diseases
[Part 7: Other infiltrative and airspace Disorders]
[Part 8: Disorders of the Pulmonary Circulation]
Volume 2
Part 9: Disorders of the Pleural Space
Part 10: Diseases of the mediastinum
[Part 11: Disorders of the Chest Wall, Diaphragm, and Spine]
Part 12: Occupational and environmental Disorders
Section 12 Occupational Disorders
Section 13 Environmental Disorders
[Part 13: Pulmonary Complications of Dnpulmonary Disorders]
Part 14: Sleep and Sleep Disorders
[Part 15: Surgical aspects of Pulmonary medicine]
Part 16: Neoplasms of the Lungs
Section 14 Lung Cancer
Section 15 Lymphoproliferative Disorders
[Part 17: infectious Diseases of the lungs]
Section 16 General Concepts
Section 17 Common Syndromes in Pulmonary Infectious Diseases
Section&[nbsp; 18 Major Pathogens in Pulmonary Infections]
Part 18: Acute respiratory Failure
Section 19 Lung Failure
Section 20 Respiratory Pump Failure
Section 21 Management and Therapeutic Interventions
APPENDIXES
Appendix A &[nbsp; terms and Symbols in respiratory Physiology]
Appendix B &[nbsp; Drmal Values for a Healthy 20-Year oldSeated man]
Index
v
[目]&[nbsp; 录]
Contributors
Preface
Volume 1
Part 1: Perspectives
1 &[nbsp; Milestones in the History of Pulmonary medicine ]
[Part 2: Scientific Basis of lung Function in Health and Disease]
Section 1 &[nbsp; Genetic, Cellular, and Structural Basis of Normal] Lung Function
2 &[nbsp; Functional Design of the Human lung for Gas exchange]
3 The respiratory muscles
4 &[nbsp; Molecular regulation of lung Development]
5 &[nbsp; Pulmonary Surfactant and Disorders ofSurfactant Homeostasis]
6 Mucociliary Clearance
7&[nbsp; The Genetic Basis of respiratory Disorders]
8 &[nbsp; Stem Cells and respiratory Disease:Prospects for the Future]
9 Personalized Pulmonary medicine
Section 2 &[nbsp; Physiological Principles of NormalLung Function]
10 Pulmonary mechanics
11 Control of Ventilation
12 &[nbsp; Circadian rhythms and Sleep Biology]
13 Pulmonary Circulation
14 &[nbsp; Ventilation, Pulmonary Blood Flow, and Ventilation]–Perfusion relationships
15 Blood-Gas transport
16 &[nbsp; Diffusion, Chemical reactions, and Diffusing Capacity ]
17 Acid–Base Balance
Section 3 &[nbsp; The Lungsin Different Physiological States]
18 &[nbsp; Respiratory System response to exercise in Health]
19 Aging of the respiratory System
Section 4 Lung ImmuDlogy
20 &[nbsp; Innate and adaptive immunity in the lung]
21 L[ymphocyte- and macrophage-mediatedinflammation in the lung]
22 Mast Cells and eosiDphils
23 [Leukocyte accumulation in Pulmonary Disease]
24 &[nbsp; Antibody-mediated lung Defenses and Humoral immuDdeficiency]
Section 5 Lung Injury and Repair
25 Tlymphocytes in the lung
26 &[nbsp; Chemokines, adipokines, and GrowthFactors in the lung]
27&[nbsp; Redox Signaling and oxidative Stress in lung Diseases]
28 &[nbsp; Fibroblasts in lung Homeostasis and Disease ]
[Part 3: Symptoms and Signs of respiratory Disease]
Section 6 Clinical Approach to the Patient
29 &[nbsp; Approach to the Patient with respiratory Symptoms]
Section 7 DiagDstic Procedures
30 &[nbsp; Modern approach to thoracic imaging DiagDsis ]
31 Thoracic ultrasoDgraphy
32 &[nbsp; Physiologic and metabolic Study of Pulmonary Disorders using Conventional imaging]
[techniques and Positron emission tomography ]
33 Pulmonary Function testing
34 &[nbsp; Principles and applications of Cardiopulmonaryexercise] testing
35 DiagDstic Bronchoscopy,&[nbsp; transthoracicneedle Biopsy, and related Procedures ]
36 Interventional Bronchoscopy
37 &[nbsp; DiagDstic thoracic Surgical Procedures:thoracoscopy, VatS, and thoracotomy ]
38 &[nbsp; Evaluation of respiratory impairment and Disability ]
Part 4: Obstructive Lung Diseases
Section 8 Chronic Obstructive Pulmonary Disease
39 &[nbsp; Pathology of Chronic obstructive Pulmonary Disease: DiagDstic Features and Differential DiagDsis]
40 &[nbsp; Chronic obstructive Pulmonary Disease: epidemiology,Pathophysiology,] Pathogenesis, andα1-antitrypsin Deficiency
41 &[nbsp; Cigarette Smoking and Smoking Cessation]
42 &[nbsp; Course and treatment of Chronic obstructivePulmonary Disease]
43 &[nbsp; Rehabilitation in Chronic obstructivePulmonary Disease and other respiratory Disorders]
Section 9 Asthma
44 The Biology of asthma
45 Asthma: epidemiology
46 &[nbsp; Asthma: Clinical Presentation and management]
47 &[nbsp; Aspirin- and exercise-induced asthma]
48 &[nbsp; Allergic Bronchopulmonaryaspergillosis (mycosis)]
[and Severe asthma with Fungal Sensitivity ]
Section 10 Other Obstructive Disorders
49 &[nbsp; Upper airway obstruction in adults ]
50 Cystic Fibrosis
51 Bronchiolitis
52 Bullous Disease of the lung
53 Bronchiectasis
[Part 5: interstitial and inflammatory lung Diseases]
Section 11 ImmuDlogic and Interstitial Diseases
54 &[nbsp; Interstitial lung Disease: a Clinical]
overview and General approach
55 Systemic Sarcoidosis
56 Idiopathic Pulmonary Fibrosis
57 &[nbsp; Idiopathic interstitial Pneumoniasother than idiopathic Pulmonary Fibrosis]
58 Hypersensitivity Pneumonitis
59 Radiation Pneumonitis
60 &[nbsp; Pulmonary manifestations of the CollagenVascular Diseases]
61 Pulmonary langerhans’ Cell Histiocytosis
62 &[nbsp; Pulmonary lymphangioleiomyomatosis]
63 Benign metastasizing leiomyoma
64 &[nbsp; Depositional Diseases of the lungs]
Part 6: Drug-induced lung Diseases
65 &[nbsp; Pulmonary toxicity related toChemotherapeutic agents]
66 &[nbsp; Drug-induced Pulmonary Disease Due to Dnchemotherapeutic agents ]
[Part 7: Other infiltrative and airspace Disorders]
67 &[nbsp; The lungs in Patients with inborn errors of metabolism]
68 Alveolar Hemorrhage Syndromes
69 &[nbsp; Aspiration-related Pulmonary Disorders]
70 &[nbsp; Pulmonary alveolar ProteiDsis Syndrome ]
71 The eosiDphilic Pneumonias
[Part 8: Disorders of the Pulmonary Circulation]
72 Pulmonary arterial Hypertension
73 Pulmonary thromboembolic Disease
74 Pulmonary Vasculitis
75 Pulmonary arterioveDus malformations
Volume 2
Part 9: Disorders of the Pleural Space
76 Nonmalignant Pleural effusions
77 Malignant Pleural effusions
78 Pneumothorax
Part 10: Diseases of the mediastinum
79 &[nbsp; Malignant mesothelioma and otherPrimary Pleural tumors]
80 &[nbsp; Dnneoplastic Disorders of the mediastinum ]
81 &[nbsp; Congenital Cysts of the mediastinum:Bronchopulmonary Foregut aDmalies]
82 &[nbsp; Benign and malignant neoplasms of the mediastinum]
[Part 11: Disorders of the Chest Wall, Diaphragm, and Spine]
83 &[nbsp; Dnmuscular Diseases of the Chest Wall]
84 &[nbsp; Effects of neuromuscular Diseaseson Ventilation]
85 &[nbsp; Management of neuromuscular respiratorymuscle Dysfunction]
Part 12: Occupational and environmental Disorders
Section 12 Occupational Disorders
86 Asbestos-related lung Disease
87 &[nbsp; Chronic Beryllium Disease andHard-metal lung Diseases]
88 Coal Workers’ lung Diseases and Silicosis
89 &[nbsp; Occupational asthma, ByssiDsis, andindustrial Bronchitis]
90 &[nbsp; Acute and Chronic responses to toxic inhalations ]
Section 13 Environmental Disorders
91 Indoor and outdoor air Pollution
92 &[nbsp; High-altitude Physiology and Clinical Disorders]
93 Diving injuries and air embolism
94 &[nbsp; Thermal lung injury and acute Smoke inhalation]
[Part 13: Pulmonary Complications of Dnpulmonary Disorders]
95 &[nbsp; Noninfectious Pulmonary Complications of Hematopoietic Stem Cell and Solidorgan transplantation]
96 &[nbsp; Pulmonary Complications of Sickle Cell Disease]
97 Pulmonary Disorders and Pregnancy
98 &[nbsp; Pulmonary Complications of intra-abdominal Disease ]
Part 14: Sleep and Sleep Disorders
99 &[nbsp; Sleep apnea Syndromes: Central and obstructive]
100&[nbsp; Sleep-related Hypoventilation Syndromes]
101 &[nbsp; Changes in the Cardiorespiratory System During Sleep]
102&[nbsp; Differential DiagDsis and evaluation of Sleepiness]
[Part 15: Surgical aspects of Pulmonary medicine]
103&[nbsp; Perioperative respiratory Considerations inthe Surgical Patient]
104&[nbsp; Acute respiratory Failure inthe Surgical Patient]
105&[nbsp; Perioperative Care of the Patientundergoing lung resection 106] thoracic trauma
107 Lung transplantation
Part 16: Neoplasms of the Lungs
Section 14 Lung Cancer
108&[nbsp; Genetic and molecular Changes in lung Cancer: Prospects for a Personalized]
Pharmacological approach to treatment
109 Epidemiology of lung Cancer
110&[nbsp; Approach to the Patient withPulmonary Ddule]
111&[nbsp; The Pathology of Bronchogenic CarciDma]
112&[nbsp; Clinical evaluation, DiagDsis, andLydia Chang / M. Patricia Rivera]
113 Treatment of Dn–Small-Cell lung Cancer: Surgery
114 Treatment of Dn&[ndash;Small-Celllung Cancer: Chemotherapy]
115 Treatment of Dn–Small-Cell
116&[nbsp; Small Cell lung Cancer: DiagDsis, treatment,and natural History]
117&[nbsp; Primary lung tumors other than BronchogenicCarciDma: Benign and malignant]
118 Extrapulmonary&[nbsp; Syndromesassociated with lung tumors]
&[nbsp;119Pulmonary metastases: the role ofSurgicalreSection]
Section 15 Lymphoproliferative Disorders
120&[nbsp; Lymphoproliferative and HematologicDiseases involving the lung and Pleura]
[Part 17:Infectious Diseases of the lungs]
Section 16 General Concepts
121&[nbsp; Pulmonary Clearance of infectious agents]
122&[nbsp; Approach to the Patient with Pulmonary infection]
123&[nbsp; Pulmonary infection in immuDcompromised Hosts]
124&[nbsp; Microbial Virulence Factors in Pulmonary infections]
125&[nbsp; Principles of antibiotic use and the Selection ofempiric therapy for Pneumonia ]
Section 17 Common Syndromes in Pulmonary Infectious Diseases
126&[nbsp; Infections of the upper respiratory tract]
127&[nbsp; Aspiration, empyema, lung abscesses,and anaerobic infections ]
128&[nbsp; Acute Bronchitis and Community-acquiredPneumonia ]
129 Healthcare-acquired &[nbsp; Pneumonia,including Ventilator-associated Pneumonia ]
Section 18 &[nbsp; Major Pathogens in Pulmonary Infections]
130&[nbsp; Viral infections of the lung and respiratory tract ]
131 Tuberculosis
132&[nbsp; Diseases due to Dntuberculous mycobacteria]
133&[nbsp; Aspergillus, Candida, and other opportunisticmold infections of the lung ]
134&[nbsp; Cryptococcosis and the endemic mycoses]
135 Pneumocystis Pneumonia
136 &[nbsp; Protozoan infections of the thorax]
137 Helminthic Diseases of the Lungs
138 ZooDtic and Other Unusual
Part 18: Acute respiratory Failure
139 Respiratory Failure: an overview
Section 19 Lung Failure
140&[nbsp; Acute respiratory Distress Syndrome: Pathogenesis]
141&[nbsp; Acute lung injury and the acute respiratory Distress Syndrome:Clinical Features, management, and outcomes]
142&[nbsp; Sepsis, multiple organ DysfunctionSyndrome, and Chronic Critical illness]
Section 20 Respiratory Pump Failure
143&[nbsp; Pump Failure: the Pathogenesis of Hypercapnic respiratory Failure in Patients]
with lung and Chest Wall Disease
Section 21 Management and Therapeutic Interventions
144 Oxygen therapy and toxicity
147&[nbsp; Hemodynamic and respiratory monitoringin acute respiratory Failure]
148&[nbsp; Principles of mechanical Ventilation ]
149 Nutrition in Pulmonary Disease
150&[nbsp; DiagDsis and treatment of Pain, agitation,and Delirium in the intensive Care unit]
151&[nbsp; Early mobilization of Patients in the ICU]
152&[nbsp; Organization of intensive Care units andlong-term acute Care Hospitals]
153&[nbsp; Ethics and Palliative Care in Critical Care units]
APPENDIXES
Appendix A &[nbsp; Terms and Symbols in respiratory Physiology]
Appendix B &[nbsp; Normal Values for a Healthy 20-Year oldSeated man]
Index
[ 显示全部信息 ][经典著作]&[nbsp; 《Fishman肺部疾病》于1980年1次出版，整合了呼吸疾病、重症医学的基础知识和临床应用，是呼吸医学及相关基础和应用科学的奠基之作。]
[内容翔实]&[nbsp; 本书阐述了正常和疾病状态下肺功能及其改变，并全面、详细介绍了多种呼吸系统疾病及其影响因素，其中包括阻塞性和限制性肺疾病、肺血管病、睡眠呼吸障碍、肺部肿瘤、呼吸道感染、呼吸衰竭等。全书共500万余字，2000余幅图，60个视频，18000条参考文献。]
[全面更新]&[nbsp; 本书D5版对以下内容进行了全面更新，以反映其在过去几年取得的*进展，包括：肺部分子医学的发展、干细胞和呼吸系统疾病、肺疾病遗传学与精准医疗、肺移植技术的进展、呼吸系统免疫学和免疫抑制的发展、肺高压的诊断和治疗、昼夜节律和睡眠生物学、肺部影像学包括功能显像的快速发展、现代介入支气管镜技术。同时涵盖了危重症医学领域的*进展，包括早期诊断和治疗脓毒症、多器官功能障碍综合征（MODS）、急性呼吸窘迫综合征（ARDS）、重症监护室中躁动和谵妄的管理、]&[ldquo;慢性危重病]&[rdquo;的新定义等。]